» Articles » PMID: 24098737

Four MicroRNAs Promote Prostate Cell Proliferation with Regulation of PTEN and Its Downstream Signals in Vitro

Overview
Journal PLoS One
Date 2013 Oct 8
PMID 24098737
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Phosphatase and tensin homologue (PTEN), as a tumor suppressor, plays vital roles in tumorigenesis and progression of prostate cancer. However, the mechanisms of PTEN regulation still need further investigation. We here report that a combination of four microRNAs (miR-19b, miR-23b, miR-26a and miR-92a) promotes prostate cell proliferation by regulating PTEN and its downstream signals in vitro.

Methodology/principal Findings: We found that the four microRNAs (miRNAs) could effectively suppress PTEN expression by directly interacting with its 3' UTR in prostate epithelial and cancer cells. Under-expression of the four miRNAs by antisense neutralization up-regulates PTEN expression, while overexpression of the four miRNAs accelerates epithelial and prostate cancer cell proliferation. Furthermore, the expression of the four miRNAs could, singly or jointly, alter the expression of the key components in the phosphoinositide 3-kinase (PI3K)/Akt pathway, including PIK3CA, PIK3CD, PIK3R1 and Akt, along with their downstream signal, cyclin D1.

Conclusions: These results suggested that the four miRNAs could promote prostate cancer cell proliferation by co-regulating the expression of PTEN, PI3K/Akt pathway and cyclin D1 in vitro. These findings increase understanding of the molecular mechanisms of prostate carcinogenesis and progression, even provide valuable insights into the diagnosis, prognosis, and rational design of novel therapeutics for prostate cancer.

Citing Articles

A systematic review of mechanisms of PTEN gene down-regulation mediated by miRNA in prostate cancer.

Bergez-Hernandez F, Irigoyen-Arredondo M, Martinez-Camberos A Heliyon. 2024; 10(15):e34950.

PMID: 39144981 PMC: 11320309. DOI: 10.1016/j.heliyon.2024.e34950.


Pancreatic cancer cells hijack tumor suppressive microRNA-26a to promote radioresistance and potentiate tumor repopulation.

Jiang M, Lin C, Liu F, Mei Z, Gu D, Tian L Heliyon. 2024; 10(10):e31346.

PMID: 38807872 PMC: 11130661. DOI: 10.1016/j.heliyon.2024.e31346.


Urinary miRNAs: Technical Updates.

Raveendran S, Al Massih A, Al Hashmi M, Saeed A, Al-Azwani I, Mathew R Microrna. 2024; 13(2):110-123.

PMID: 38778602 DOI: 10.2174/0122115366305985240502094814.


Urinary MicroRNAs as Biomarkers of Urological Cancers: A Systematic Review.

Aveta A, Cilio S, Contieri R, Spena G, Napolitano L, Manfredi C Int J Mol Sci. 2023; 24(13).

PMID: 37446024 PMC: 10341705. DOI: 10.3390/ijms241310846.


Deregulated microRNAs Involved in Prostate Cancer Aggressiveness and Treatment Resistance Mechanisms.

Gujrati H, Ha S, Wang B Cancers (Basel). 2023; 15(12).

PMID: 37370750 PMC: 10296615. DOI: 10.3390/cancers15123140.


References
1.
Sramkoski R, Pretlow 2nd T, Giaconia J, Pretlow T, Schwartz S, Sy M . A new human prostate carcinoma cell line, 22Rv1. In Vitro Cell Dev Biol Anim. 1999; 35(7):403-9. DOI: 10.1007/s11626-999-0115-4. View

2.
Engelman J . Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat Rev Cancer. 2009; 9(8):550-62. DOI: 10.1038/nrc2664. View

3.
Chun-Zhi Z, Lei H, An-Ling Z, Yan-Chao F, Xiao Y, Guang-Xiu W . MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN. BMC Cancer. 2010; 10:367. PMC: 2914702. DOI: 10.1186/1471-2407-10-367. View

4.
Cantley L . The phosphoinositide 3-kinase pathway. Science. 2002; 296(5573):1655-7. DOI: 10.1126/science.296.5573.1655. View

5.
Zhang J, Wang J, Zhao F, Liu Q, Jiang K, Yang G . MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC). Clin Chim Acta. 2010; 411(11-12):846-52. DOI: 10.1016/j.cca.2010.02.074. View